Target intelligence / Profile preview

Immunoglobulin heavy variable 3-47 (pseudogene) (IGHV3-47)

Target
IGHV3-47
Molecular classification
Other (Immunoglobulin gene segment, Pseudogene)
01

Overview

Immunoglobulin heavy variable 3-47 (IGHV3-47) is annotated as a pseudogene within the immunoglobulin heavy chain locus in humans, specifically as a member of the IGHV3 subgroup[3][4]. The immunoglobulin heavy-chain locus is composed of multiple variable (VH), diversity (DH), and joining (JH) gene segments, which undergo somatic recombination to generate antibody diversity in B cells[1][2]. However, as a pseudogene, IGHV3-47 does not produce a functional heavy-chain variable region and is not involved in mature antibody expression. Its primary significance is as a marker for genomic studies of antibody gene diversity and evolution but it is not considered a canonical therapeutic target, receptor, enzyme, or protein product.\n\nKey context:\n- This segment is widely listed in genomic databases as a pseudogene and not known to encode a functional, expressed immunoglobulin chain in humans[3][4].\n- As such, it does not have therapeutic relevance and is not associated with known mechanisms of drug action, disease roles, or established biomarkers.\n- The IGHV family as a whole is critical to antibody generation, but IGHV3-47 specifically is non-functional in humans and therefore not a direct target in therapeutic intervention or pharmacology.\n\nDue to this, the entry "immunoglobulin heavy variable 3-47" is not a canonical drug target and has no associated drug mechanism or disease relevance in currently available data.

Other names
IGHV3-47 (pseudogene)3-47PIGHV347IGHV3-H
02

Biological functions

Other (Genomic element; non-functional pseudogene in humans)

Beyond the preview

Go deeper on Immunoglobulin heavy variable 3-47 (pseudogene) (IGHV3-47).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 3-47 (pseudogene) (IGHV3-47).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call